|1.||Jacques, Loretta: 17 articles (12/2015 - 01/2011)|
|2.||Woodcock, Ashley: 16 articles (12/2015 - 01/2011)|
|3.||Bateman, Eric D: 15 articles (12/2015 - 01/2011)|
|4.||Wu, Wei: 14 articles (01/2015 - 03/2007)|
|5.||Lötvall, Jan: 13 articles (09/2014 - 01/2011)|
|6.||Busse, William W: 13 articles (09/2014 - 01/2011)|
|7.||Bleecker, Eugene R: 12 articles (09/2014 - 01/2011)|
|8.||Crim, Courtney: 10 articles (06/2015 - 08/2012)|
|9.||Forth, Richard: 8 articles (12/2015 - 01/2011)|
|10.||O'Byrne, Paul M: 8 articles (12/2015 - 06/2013)|
|1.||Perennial Allergic Rhinitis
01/01/2007 - "In children aged 6-11 years, fluticasone furoate nasal spray was shown to be effective in reducing the nasal symptoms of seasonal and perennial allergic rhinitis following treatment for 2 and 4 weeks, respectively. "
01/01/2015 - "Safety and efficacy of fluticasone furoate nasal spray in Japanese children 2 to <15 years of age with perennial allergic rhinitis: a multicentre, open-label trial."
01/01/2010 - "The safety and efficacy of fluticasone furoate nasal spray (FFNS) for the symptoms of seasonal and perennial allergic rhinitis have been previously demonstrated in several clinical studies. "
05/01/2013 - "An integrated analysis of the efficacy of fluticasone furoate nasal spray versus placebo on the nasal symptoms of perennial allergic rhinitis."
01/01/2008 - "To evaluate the safety and efficacy of once-daily (QD) fluticasone furoate (FF) nasal spray in children with perennial allergic rhinitis (PAR). "
|2.||Asthma (Bronchial Asthma)
01/01/2014 - "Fluticasone furoate (FF) is a novel, once-daily inhaled corticosteroid (ICS) that has been shown to improve lung function vs. placebo in asthma patients. "
05/01/2012 - "This randomized, double-blind, multicenter study was designed to evaluate the efficacy of inhaled once-daily fluticasone furoate (FF) administered in the evening in patients with persistent asthma not controlled by short-acting beta(2) agonists, and to determine the dose(s) suitable for further development. "
01/01/2015 - "The effect of fluticasone furoate/umeclidinium in adult patients with asthma: a randomized, dose-ranging study."
11/01/2014 - "Once-daily fluticasone furoate 50 mcg in mild-to-moderate asthma: a 24-week placebo-controlled randomized trial."
01/01/2014 - "Efficacy and safety of once-daily fluticasone furoate 50 mcg in adults with persistent asthma: a 12-week randomized trial."
|3.||Seasonal Allergic Rhinitis (Hay Fever)
01/01/2007 - "In well controlled clinical trials, intranasal fluticasone furoate 110microg once daily for 2 weeks in adults and adolescents with seasonal allergic rhinitis reduced nasal and ocular symptoms, and improved health-related quality of life to a significantly greater extent than placebo. "
09/01/2007 - "Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen."
11/01/2010 - "An integrated analysis of the efficacy of fluticasone furoate nasal spray on individual nasal and ocular symptoms of seasonal allergic rhinitis."
05/01/2009 - "The objective of this study was to evaluate the efficacy and safety of fluticasone furoate (FF) nasal spray 55 and 110 microg once daily in children with seasonal allergic rhinitis (SAR). "
09/01/2007 - "In this multicentre, randomized, double-blind, placebo-controlled, parallel-group study, patients [adults and adolescents >or=12 years of age with seasonal allergic rhinitis (SAR)] received once-daily (od) treatment for 2 weeks with either fluticasone furoate nasal spray 110 microg (n = 141) or placebo nasal spray (n = 144) administered in a unique, side-actuated device. "
|4.||Chronic Obstructive Pulmonary Disease (COPD)
12/01/2015 - "Recently, fluticasone furoate/vilanterole (FF/VI) has been approved as the first once-daily ICS/LABA combination therapy for asthma and COPD. "
01/01/2015 - "To determine the incidence of pneumonia, risk factors, and clinical attributes with inhaled fluticasone furoate (FF) in patients with COPD with an exacerbation history. "
09/01/2014 - "In phase 3 trials in patients with moderate to very severe COPD, overall, once-daily fluticasone furoate/vilanterol 100/25 µg improved pulmonary function more than placebo and fluticasone furoate alone and improved exacerbation rates more than vilanterol alone. "
09/01/2015 - "The aim of these studies (NCT01957163; NCT02119286) was to evaluate the efficacy and safety of umeclidinium (UMEC 62.5 μg and 125 μg) added to fluticasone furoate/vilanterol (FF/VI, 100/25 μg) in chronic obstructive pulmonary disease (COPD). "
09/01/2015 - "Efficacy and safety of umeclidinium added to fluticasone furoate/vilanterol in chronic obstructive pulmonary disease: Results of two randomized studies."
08/01/2007 - "Fluticasone furoate is a recently approved, enhanced- affinity intranasal corticosteroid with low systemic bioavailability and proven efficacy in treating allergic rhinitis. "
02/01/2011 - "Efficacy of fluticasone furoate nasal spray vs. placebo for the treatment of ocular and nasal symptoms of allergic rhinitis: a systematic review."
01/01/2009 - "Safety and tolerability of fluticasone furoate nasal spray once daily in paediatric patients aged 6-11 years with allergic rhinitis: subanalysis of three randomized, double-blind, placebo-controlled, multicentre studies."
08/01/2007 - "In this study, fluticasone furoate nasal spray 110 microg QD for 2 weeks had no effect on lower-leg growth rate in these prepubertal children with allergic rhinitis."
08/01/2007 - "The aim of the current study was to assess whether treatment with fluticasone furoate nasal spray affected the short-term lower-leg growth rate in children with allergic rhinitis. "
|1.||4- (2- ((6- ((2- (((2,6- dichlorophenyl)methyl)oxy)ethyl)oxy)hexyl)amino)- 1- hydroxyethyl)- 2- (hydroxymethyl)phenol
|7.||mometasone furoate (mometasone)
|9.||Adrenal Cortex Hormones (Corticosteroids)
|10.||Interleukin-6 (Interleukin 6)
|1.||Dry Powder Inhalers
|3.||Nebulizers and Vaporizers (Inhaler)